Skip to main content

Cearnal Martin E's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Aug 13, 2021

Accession no.
0001209191-21-051433
Filed
Aug 13, 2021
Trade date
Jun 30-Jul 30, 2021
Filing delay
44 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 22 non-derivative transactions. Open-market purchases total $7.51K. It was filed 44 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Cearnal Martin ECIK 0001408500Director, Officer (Sr VP/Chief Commercial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 30, 2021Common StockPPurchaseAcquired+105$2.93+$307.65165,054Direct
Jul 1, 2021Common StockPPurchaseAcquired+105$2.91+$305.55165,159Direct
Jul 2, 2021Common StockPPurchaseAcquired+105$2.94+$308.7165,264Direct
Jul 6, 2021Common StockPPurchaseAcquired+105$3.14+$329.7165,369Direct
Jul 7, 2021Common StockPPurchaseAcquired+105$3.19+$334.95165,474Direct
Jul 8, 2021Common StockPPurchaseAcquired+105$3.18+$333.9165,579Direct
Jul 9, 2021Common StockPPurchaseAcquired+105$3.13+$328.65165,684Direct
Jul 12, 2021Common StockPPurchaseAcquired+105$3.33+$349.65165,789Direct
Jul 13, 2021Common StockPPurchaseAcquired+105$3.48+$365.4165,894Direct
Jul 14, 2021Common StockPPurchaseAcquired+105$3.33+$349.65165,999Direct
Jul 15, 2021Common StockPPurchaseAcquired+105$3.27+$343.35166,104Direct
Jul 16, 2021Common StockPPurchaseAcquired+105$3.28+$344.4166,209Direct
Jul 19, 2021Common StockPPurchaseAcquired+105$3.23+$339.15166,314Direct
Jul 20, 2021Common StockPPurchaseAcquired+105$3.24+$340.2166,419Direct
Jul 21, 2021Common StockPPurchaseAcquired+105$3.26+$342.3166,524Direct
Jul 22, 2021Common StockPPurchaseAcquired+105$3.36+$352.8166,629Direct
Jul 23, 2021Common StockPPurchaseAcquired+105$3.35+$351.75166,734Direct
Jul 26, 2021Common StockPPurchaseAcquired+105$3.39+$355.95166,839Direct
Jul 27, 2021Common StockPPurchaseAcquired+105$3.39+$355.95166,944Direct
Jul 28, 2021Common StockPPurchaseAcquired+105$3.42+$359.1167,049Direct
Jul 29, 2021Common StockPPurchaseAcquired+105$3.42+$359.1167,154Direct
Jul 30, 2021Common StockPPurchaseAcquired+105$3.31+$347.55167,259Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)